Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 4/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3696144 | 1.00 | LMNA (0.49) | LMNATSHRHTTKDM4EALDH1A1 | |
| SCHEMBL5706651 | 0.85 | POLA1 (0.33) | LMNA | |
| SCHEMBL5706650 | 0.85 | POLA1 (0.33) | LMNA | |
| SCHEMBL2170337 | 0.84 | LMNA (0.67) | LMNATSHRHTTKDM4EALDH1A1 | |
| SCHEMBL29246835 | 0.84 | LMNA (0.67) | LMNATSHRHTTKDM4EALDH1A1 | |
| SCHEMBL2168536 | 0.84 | LMNA (0.67) | LMNATSHRHTTKDM4EALDH1A1 | |
| SCHEMBL2168541 | 0.84 | LMNA (0.67) | LMNATSHRHTTKDM4EALDH1A1 | |
| SCHEMBL3697228 | 0.79 | — | — | |
| SCHEMBL3697230 | 0.79 | — | — | |
| SCHEMBL19697508 | 0.74 | LMNA (0.43) | LMNATSHRHTTKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1792889-B1 | Process for the preparation of carboxylic acid esters | SUMITOMO CHEMICAL CO (JP) | 2015-03-04 | — | — | EP | disclosed |
| EP-1547995-B1 | Process for the preparation of carboxylic acid esters | SUMITOMO CHEMICAL CO (JP) | 2014-05-07 | — | — | EP | disclosed |
| US-7741511-B2 | Process for the preparation of carboxylic acid esters | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-22 | — | — | US | disclosed |
| US-7399873-B2 | Process for the preparation of carboxylic acid esters | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-07-15 | — | — | US | disclosed |
| US-20080033194-A1 | PROCESS FOR THE PREPARATION OF CARBOXYLIC ACID ESTERS | SOUDA HIROSHI | 2008-02-07 | — | — | US | disclosed |
| US-20080009648-A1 | PROCESS FOR THE PREPARATION OF CARBOXYLIC ACID ESTERS | SOUDA HIROSHI | 2008-01-10 | — | — | US | disclosed |
| EP-1792889-A2 | Process for the preparation of carboxylic acid esters | Sumitomo Chemical Company, Limited (JP) | 2007-06-06 | — | — | EP | disclosed |
| EP-1547995-A1 | Process for the preparation of carboxylic acid esters | Sumitomo Chemical Company, Limited (JP) | 2005-06-29 | — | — | EP | disclosed |
| US-20050113581-A1 | Process for the preparation of carboxylic acid esters | SUMITOMO CHEMICAL COMPANY, LIMITED | 2005-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113581-A1 | Process for the preparation of carboxylic acid esters | ACSL6, ALKBH3, ACSL1 | LMNA 3667/4885TSHR 1811/4885HTT 4690/4885 |
| US-20080033194-A1 | PROCESS FOR THE PREPARATION OF CARBOXYLIC ACID ESTERS | ACSL6, ALKBH3, ACSL1 | LMNA 3667/4885TSHR 1811/4885HTT 4690/4885 |
| US-20080009648-A1 | PROCESS FOR THE PREPARATION OF CARBOXYLIC ACID ESTERS | ACSL6, ALKBH3, ACSL1 | LMNA 3667/4885TSHR 1811/4885HTT 4690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.